Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

Contact Supplier

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

DEVELOPMENTS

22 Drugs in Development

22 Drugs in Development

DIGITAL CONTENT

5 NEWS #PharmaBuzz

media
5 NEWS #PharmaBuzz

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

22DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: Dgn7roz8en, Atuzaginstat [inn], 2211981-76-7, Cyclopentanecarboxamide, n-((1s)-5-amino-1-(2-(2,3,6-trifluorophenoxy)acetyl)pentyl)-, N-((3s)-7-amino-2-oxo-1-(2,3,6- trifluorophenoxy)heptan-3-yl)cyclopentanecarboxamide, Unii-dgn7roz8en

Molecular Formula

C₁₉H₂₅F₃N₂O₃

Molecular Weight

386.4 g/mol

InChI Key

OLIMBXKACVCIMM-HNNXBMFYSA-N

FDA UNII

DGN7ROZ8EN

1 2D Structure

Atuzaginstat

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

N-[(3S)-7-amino-2-oxo-1-(2,3,6-trifluorophenoxy)heptan-3-yl]cyclopentanecarboxamide

2.1.2 InChI

InChI=1S/C19H25F3N2O3/c20-13-8-9-14(21)18(17(13)22)27-11-16(25)15(7-3-4-10-23)24-19(26)12-5-1-2-6-12/h8-9,12,15H,1-7,10-11,23H2,(H,24,26)/t15-/m0/s1

2.1.3 InChI Key

OLIMBXKACVCIMM-HNNXBMFYSA-N

2.1.4 Canonical SMILES

C1CCC(C1)C(=O)NC(CCCCN)C(=O)COC2=C(C=CC(=C2F)F)F

2.1.5 Isomeric SMILES

C1CCC(C1)C(=O)N[C@@H](CCCCN)C(=O)COC2=C(C=CC(=C2F)F)F

2.2 Other Identifiers

2.2.1 UNII

DGN7ROZ8EN

2.3 Synonyms

2.3.1 MeSH Synonyms

1. Cor388

2.3.2 Depositor-Supplied Synonyms

1. Dgn7roz8en

2. Atuzaginstat [inn]

3. 2211981-76-7

4. Cyclopentanecarboxamide, N-((1s)-5-amino-1-(2-(2,3,6-trifluorophenoxy)acetyl)pentyl)-

5. N-((3s)-7-amino-2-oxo-1-(2,3,6- Trifluorophenoxy)heptan-3-yl)cyclopentanecarboxamide

6. Unii-dgn7roz8en

7. Cor388

8. Schembl19972758

9. Cor-388

10. Bdbm453275

11. Ex-a6081

12. Us10730826, Compound 1a-racemic

13. Us10730826, Compound 1a-non-racemic

14. N-[(3s)-7-amino-2-oxo-1-(2,3,6-trifluorophenoxy)heptan-3-yl]cyclopentanecarboxamide

2.4 Create Date

2018-06-23

3 Chemical and Physical Properties

Molecular Formula	C₁₉H₂₅F₃N₂O₃
Molecular Weight	386.4 g/mol
XLogP3	3
Hydrogen Bond Donor Count	2
Hydrogen Bond Acceptor Count	7
Rotatable Bond Count	10
Exact Mass	386.18172715 g/mol
Monoisotopic Mass	386.18172715 g/mol
Topological Polar Surface Area	81.4 Å²
Heavy Atom Count	27
Formal Charge	0
Complexity	489
Isotope Atom Count	0
Defined Atom Stereocenter Count	1
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1